Skip to main content

Advertisement

Log in

High expression of CEACAM19, a new member of carcinoembryonic antigen gene family, in patients with breast cancer

  • Original Article
  • Published:
Clinical and Experimental Medicine Aims and scope Submit manuscript

Abstract

Carcinoembryonic antigen (CEA) family members play important roles in malignancies and are introduced as biomarkers in different types of cancers. Among them CEACAM19 (CEAL1) gene, a new member of the CEA family, remains to be fully elucidated. The aim of this study was investigating the mRNA expression level of CEACAM19 in tumor samples of breast cancer patients compared to breast tissue of normal individuals. We evaluated the expression level of this gene in 75 breast tumors by using real-time quantitative PCR. Also, we studied the correlation between CEACAM19 expression and clinicopathological features and hormone receptors status, including estrogen receptor (ER), progesterone receptor (PR) and human epidermal growth factor receptor 2 of patients. Out of the enrolled patients, six of them (7.9%) showed low expression, ten (13.2%) showed normal expression and 59 (77.6%) showed high expression of CEACAM19. There was a significant correlation between high expression of CEACAM19 gene in tumor samples compared to normal tissues (P = 0.039). No significant correlation was seen between clinicopathological factors and disease-free survival with mRNA levels of CEACAM19 in tumor samples, while the difference between the expression of CEACAM19 in ER/PR-positive and ER/PR-negative breast cancer patients was statistically significant (P = 0.046). In conclusion, CEACAM19 showed high expression in tumor samples compared to normal mammary tissue. In addition, CEACAM19 may represent as a novel therapeutic target in certain subgroups of breast cancer patients such as ER/PR-negative. Critical roles of CEA proteins in tumor progression may nominate them as robust potential targets for therapeutic intervention in near future.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Harding C, Pompei F, Burmistrov D, Welch HG, Abebe R, Wilson R. Breast cancer screening, incidence, and mortality across US counties. JAMA Intern Med. 2015;175:1483–9.

    Article  PubMed  Google Scholar 

  2. Sharifian A, Pourhoseingholi MA, Emadedin M, et al. Burden of breast cancer in Iranian women is increasing. Asian Pac J Cancer Prev. 2015;16:5049–52.

    Article  PubMed  Google Scholar 

  3. Si W, Li Y, Han Y, et al. Epidemiological and clinicopathological trends of breast cancer in Chinese patients during 1993 to 2013: a retrospective study. Medicine. 2015;94:e820.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Györffy B, Lanczky A, Eklund AC, et al. An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients. Breast Cancer Res Treat. 2010;123:725–31.

    Article  PubMed  Google Scholar 

  5. Bogenrieder T, Herlyn M. Axis of evil: molecular mechanisms of cancer metastasis. Oncogene. 2003;22:6524–36.

    Article  CAS  PubMed  Google Scholar 

  6. Kuespert K, Pils S, Hauck CR. CEACAMs: their role in physiology and pathophysiology. Curr Opin Cell Biol. 2006;18:565–71.

    Article  CAS  PubMed  Google Scholar 

  7. Beauchemin N, Arabzadeh A. Carcinoembryonic antigen-related cell adhesion molecules (CEACAMs) in cancer progression and metastasis. Cancer Metast Rev. 2013;32:643–71.

    Article  CAS  Google Scholar 

  8. Wakabayashi-Nakao K, Hatakeyama K, Ohshima K, Yamaguchi K, Mochizuki T. Carcinoembryonic antigen-related cell adhesion molecule 4 (CEACAM4) is specifically expressed in medullary thyroid carcinoma cells. Biomed Res. 2014;35:237–42.

    Article  CAS  PubMed  Google Scholar 

  9. Blumenthal RD, Leon E, Hansen HJ, Goldenberg DM. Expression patterns of CEACAM5 and CEACAM6 in primary and metastatic cancers. BMC Cancer. 2007;7:2.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Zhou J, Zhang L, Gu Y, et al. Dynamic expression of CEACAM7 in precursor lesions of gastric carcinoma and its prognostic value in combination with CEA. World J Surg Oncol. 2011;9:172.

    Article  PubMed  PubMed Central  Google Scholar 

  11. Duxbury MS, Ito H, Zinner MJ, Ashley SW, Whang EE. CEACAM6 gene silencing impairs anoikis resistance and in vivo metastatic ability of pancreatic adenocarcinoma cells. Oncogene. 2004;23:465–73.

    Article  CAS  PubMed  Google Scholar 

  12. Singer BB, Scheffrahn I, Kammerer R, et al. Deregulation of the CEACAM expression pattern causes undifferentiated cell growth in human lung adenocarcinoma cells. PLoS ONE. 2010;5:e8747.

    Article  PubMed  PubMed Central  Google Scholar 

  13. Chan C, Stanners C. Recent advances in the tumour biology of the GPI-anchored carcinoembryonic antigen family members CEACAM5 and CEACAM6. Curr Oncol. 2007;14:70.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Horst A, Wagener C. CEA-related CAMs. Handb Exp Pharmacol. 2004;165:283–341.

    Article  CAS  Google Scholar 

  15. Tiernan J, Perry S, Verghese E, et al. Carcinoembryonic antigen is the preferred biomarker for in vivo colorectal cancer targeting. Br J Cancer. 2013;108:662–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Kim KS, Kim J-T, Lee S-J, et al. Overexpression and clinical significance of carcinoembryonic antigen-related cell adhesion molecule 6 in colorectal cancer. Clin Chim Acta. 2013;415:12–9.

    Article  CAS  PubMed  Google Scholar 

  17. Thies A, Moll I, Berger J, et al. CEACAM1 expression in cutaneous malignant melanoma predicts the development of metastatic disease. J Clin Oncol. 2002;20:2530–6.

    Article  CAS  PubMed  Google Scholar 

  18. Laack E, Nikbakht H, Peters A, et al. Expression of CEACAM1 in adenocarcinoma of the lung: a factor of independent prognostic significance. J Clin Oncol. 2002;20:4279–84.

    Article  PubMed  Google Scholar 

  19. Scorilas A, Chiang PM, Katsaros D, Yousef GM, Diamandis EP. Molecular characterization of a new gene, CEAL1, encoding for a carcinoembryonic antigen-like protein with a highly conserved domain of eukaryotic translation initiation factors. Gene. 2003;310:79–89.

    Article  CAS  PubMed  Google Scholar 

  20. Majidzadeh-A K, Kaviani A, Esmaeili R, et al. Iranian breast cancer bio-bank: the activity and challenging issues. Cell Tissue Bank. 2013;14:11–20.

    Article  CAS  PubMed  Google Scholar 

  21. Majidzadeh-A K, Esmaeili R, Abdoli N. TFRC and ACTB as the best reference genes to quantify Urokinase Plasminogen activator in breast cancer. BMC Res Notes. 2011;4:215.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Pazhoomand R, Keyhani E, Banan M, et al. Detection of HER2 status in breast cancer: comparison of current methods with MLPA and real-time RT-PCR. Asian Pac J Cancer Prev. 2013;14:7621–8.

    Article  PubMed  Google Scholar 

  23. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2015. CA-Cancer J Clin. 2015;65:5–29.

    Article  PubMed  Google Scholar 

  24. Smith RA, Manassaram-Baptiste D, Brooks D, et al. Cancer screening in the USA, 2015: a review of current American Cancer Society guidelines and current issues in cancer screening. CA Cancer J Clin. 2015;65:30–54.

    Article  PubMed  Google Scholar 

  25. Babu GR, Samari G, Cohen SP, et al. Breast cancer screening among females in Iran and recommendations for improved practice: a review. Asian Pac J Cancer Prev. 2011;12:1647–55.

    PubMed  Google Scholar 

  26. Khatib N, Pe’er J, Ortenberg R, et al. Carcinoembryonic antigen cell adhesion molecule-1 (CEACAM1) in posterior uveal melanoma: correlation with clinical and histological survival markers. Invest Ophthalmol Vis Sci. 2011;13:9368–72.

    Article  Google Scholar 

  27. Dango S, Sienel W, Schreiber M, et al. Elevated expression of carcinoembryonic antigen-related cell adhesion molecule 1 (CEACAM-1) is associated with increased angiogenic potential in non-small-cell lung cancer. Lung Cancer. 2008;60:426–33.

    Article  PubMed  Google Scholar 

  28. Zhou C-J, Liu B, Zhu K-X, et al. The different expression of carcinoembryonic antigen-related cell adhesion molecule 1 (CEACAM1) and possible roles in gastric carcinomas. Pathol Res Pract. 2009;205:483–9.

    Article  CAS  PubMed  Google Scholar 

  29. Thöm I, Schult-Kronefeld O, Burkholder I, et al. Expression of CEACAM-1 in pulmonary adenocarcinomas and their metastases. Anticancer Res. 2009;29:249–54.

    PubMed  Google Scholar 

  30. Gebauer F, Wicklein D, Horst J, et al. Carcinoembryonic antigen-related cell adhesion molecules (CEACAM) 1, 5 and 6 as biomarkers in pancreatic cancer. PLoS ONE. 2014;9:e113023.

    Article  PubMed  PubMed Central  Google Scholar 

  31. Serra S, Asa SL, Bamberger A-M, Wagener C, Chetty R. CEACAM1 expression in pancreatic endocrine tumors. Appl Immunohistochem Mol Morphol. 2009;17:286–93.

    Article  CAS  PubMed  Google Scholar 

  32. Cruz PV, Wakai T, Shirai Y, Yokoyama N, Hatakeyama K. Loss of carcinoembryonic antigen-related cell adhesion molecule 1 expression is an adverse prognostic factor in hepatocellular carcinoma. Cancer. 2005;104:354–60.

    Article  CAS  PubMed  Google Scholar 

  33. Busch C, Hanssen TA, Wagener C, Öbrink B. Down-regulation of CEACAM1 in human prostate cancer: correlation with loss of cell polarity, increased proliferation rate, and Gleason grade 3 to 4 transition. Hum Pathol. 2002;33:290–8.

    Article  CAS  PubMed  Google Scholar 

  34. Strickland LA, Ross J, Williams S, et al. Preclinical evaluation of carcinoembryonic cell adhesion molecule (CEACAM) 6 as potential therapy target for pancreatic adenocarcinoma. J Pathol. 2009;218:380–90.

    Article  CAS  PubMed  Google Scholar 

  35. Hasselbalch HC, Skov V, Larsen TS, et al. High expression of carcinoembryonic antigen-related cell adhesion molecule (CEACAM) 6 and 8 in primary myelofibrosis. Leuk Res. 2011;35:1330–4.

    Article  CAS  PubMed  Google Scholar 

  36. Messick CA, Sanchez J, DeJulius KL, Hammel J, Ishwaran H, Kalady MF. CEACAM-7: a predictive marker for rectal cancer recurrence. Surgery. 2010;147:713–9.

    Article  PubMed  Google Scholar 

  37. Michaelidou K, Tzovaras A, Missitzis I, Ardavanis A, Scorilas A. The expression of the CEACAM19 gene, a novel member of the CEA family, is associated with breast cancer progression. Int J Oncol. 2013;42:1770–7.

    Article  CAS  PubMed  Google Scholar 

  38. Hashemzadeh S, Arabzadeh AA, Estiar MA, et al. Clinical utility of measuring expression levels of Stanniocalcin 2 in patients with colorectal cancer. Med Oncol. 2014;31:237.

    Article  PubMed  Google Scholar 

  39. Saadatmand S, de Kruijf E, Sajet A, et al. Expression of cell adhesion molecules and prognosis in breast cancer. Brit J Surg. 2013;100:252–60.

    Article  CAS  PubMed  Google Scholar 

  40. Poola I, Shokrani B, Bhatnagar R, DeWitty RL, Yue Q, Bonney G. Expression of carcinoembryonic antigen cell adhesion molecule 6 oncoprotein in atypical ductal hyperplastic tissues is associated with the development of invasive breast cancer. Clin Cancer Res. 2006;12:4773–83.

    Article  CAS  PubMed  Google Scholar 

  41. Hauck W, Nedellec P, Turbide C, Stanners CP, Barnett TR, Beauchemin N. Transcriptional control of the human biliary glycoprotein gene, a CEA gene family member down-regulated in colorectal carcinomas. Eur J Biochem. 1994;223:529–41.

    Article  CAS  PubMed  Google Scholar 

  42. Kobayashi M, Miki Y, Ebina M, et al. Carcinoembryonic antigen-related cell adhesion molecules as surrogate markers for EGFR inhibitor sensitivity in human lung adenocarcinoma. Brit J Cancer. 2012;107:1745–53.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  43. Sienel W, Dango S, Woelfle U, et al. Elevated expression of carcinoembryonic antigen-related cell adhesion molecule 1 promotes progression of non-small cell lung cancer. Clin Cancer Res. 2003;9:2260–6.

    CAS  PubMed  Google Scholar 

  44. Wu X, Hawse JR, Subramaniam M, Goetz MP, Ingle JN, Spelsberg TC. The tamoxifen metabolite, endoxifen, is a potent antiestrogen that targets estrogen receptor α for degradation in breast cancer cells. Cancer Res. 2009;69:1722–7.

    Article  CAS  PubMed  Google Scholar 

  45. Motamedi S, Majidzadeh K, Mazaheri M, Anbiaie R, Mortazavizadeh SM, Esmaeili R. Tamoxifen resistance and CYP2D6 copy numbers in breast cancer patients. Asian Pac J Cancer Prev. 2012;13:6101–4.

    Article  PubMed  Google Scholar 

  46. Majidzadeh-A K, Gharechahi J. Plasma proteomics analysis of tamoxifen resistance in breast cancer. Med Oncol. 2013;30:753.

    Article  PubMed  Google Scholar 

  47. Scott D, Parkes A, Ponchel F, Cummings M, Poola I, Speirs V. Changes in expression of steroid receptors, their downstream target genes and their associated co-regulators during the sequential acquisition of tamoxifen resistance in vitro. Int J Oncol. 2007;31:557–65.

    CAS  PubMed  Google Scholar 

  48. Maraqa L, Cummings M, Peter MB, et al. Carcinoembryonic antigen cell adhesion molecule 6 predicts breast cancer recurrence following adjuvant tamoxifen. Clin Cancer Res. 2008;14:405–11.

    Article  CAS  PubMed  Google Scholar 

  49. Lewis-Wambi J, Kim H, Cunliffe H, Jordan C. Overexpression of CEACAM6 promotes invasion and migration of aromatase inhibitor-resistant breast cancer cells. Cancer Res. 2007;67:5710.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Keivan Majidzadeh-A.

Ethics declarations

Conflict of interest

There is no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Estiar, M.A., Esmaeili, R., Zare, AA. et al. High expression of CEACAM19, a new member of carcinoembryonic antigen gene family, in patients with breast cancer. Clin Exp Med 17, 547–553 (2017). https://doi.org/10.1007/s10238-016-0442-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10238-016-0442-1

Keywords

Navigation